PharmTech

CONTINUE TO SITE

OR WAIT null SECS

Advertisement

Analytics Dosage Forms Drug Development Manufacturing Outsourcing Quality Systems

AnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems

View More COVID-19 Update Analytical Method Development APIs Aseptic Processing Biologic Drugs Drug Delivery Equipment Excipients Formulation Packaging Process Control/PAT Process Development QA/QC Regulatory Action Supply Chain

COVID-19 UpdateAnalytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain

All News Top News Industry News Bio/Pharma News Supplier News News from Europe Events

All NewsTop NewsIndustry NewsBio/Pharma NewsSupplier NewsNews from EuropeEvents

All Publications PharmTech PharmTech Europe

All PublicationsPharmTechPharmTech Europe

Front & Center Pharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

Front & CenterPharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts Marketplace

Drug Digest Videos Drug Solutions Podcast

Conference Coverage Conference Listing

Enewsletters Magazine North America Magazine Europe

EnewslettersMagazine North AmericaMagazine Europe

About Us
Advertise
Contact Us
Editorial Info
Editorial Contacts
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

© 2024 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.

Thought-Leadership Series

Subcutaneous Drug Delivery

PharmTech’s Jennifer Markarian interviews David Kang of Halozyme about subcutaneous drug delivery.